Article info

Download PDFPDF
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint

Authors

  • Ricardo Grieshaber-Bouyer Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany Molecular Medicine Partnership Unit, European Molecular Biology Laboratory (EMBL), University of Heidelberg, Heidelberg, Germany Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Tarik Exner Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Nicolaj S Hackert Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Felix A Radtke Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Scott A Jelinsky Computational Systems Immunology, Worldwide Research & Development, Pfizer Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Olha Halyabar Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Alexandra Wactor Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Elham Karimizadeh Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Joseph Brennan Computational Systems Immunology, Worldwide Research & Development, Pfizer Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Jorge Schettini Computational Systems Immunology, Worldwide Research & Development, Pfizer Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Helena Jonsson Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Deepak A Rao Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Lauren A Henderson Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Carsten Müller-Tidow Molecular Medicine Partnership Unit, European Molecular Biology Laboratory (EMBL), University of Heidelberg, Heidelberg, Germany Department of Medicine V (Hematology Oncology Rheumatology), Heidelberg University Hospital, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Hanns-Martin Lorenz Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Guido Wabnitz Institute for Immunology, Heidelberg University Hospital, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • James A Lederer Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Angela Hadjipanayis Computational Systems Immunology, Worldwide Research & Development, Pfizer Inc, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Peter A Nigrovic Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ricardo Grieshaber-Bouyer, Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany; Ricardo.GrieshaberBouyer{at}med.uni-heidelberg.de; Dr Peter A Nigrovic, Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; peter.nigrovic{at}childrens.harvard.edu
View Full Text

Citation

Grieshaber-Bouyer R, Exner T, Hackert NS, et al
Ageing and interferon gamma response drive the phenotype of neutrophils in the inflamed joint

Publication history

  • Received November 16, 2021
  • Accepted February 2, 2022
  • First published February 15, 2022.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.